عرض بسيط للتسجيلة

المؤلفAl-Motawa, Maryam S.
المؤلفAbbas, Hafsa
المؤلفWijten, Patrick
المؤلفde la Fuente, Alberto
المؤلفXue, Mingzhan
المؤلفRabbani, Naila
المؤلفThornalley, Paul J.
تاريخ الإتاحة2023-08-31T19:43:57Z
تاريخ النشر2020-10-09
اسم المنشورFrontiers in Pharmacology
المعرّفhttp://dx.doi.org/10.3389/fphar.2020.585408
الاقتباسAl-Motawa, M. S., Abbas, H., Wijten, P., De la Fuente, A., Xue, M., Rabbani, N., & Thornalley, P. J. (2020). Vulnerabilities of the SARS-CoV-2 virus to proteotoxicity—opportunity for repurposed chemotherapy of COVID-19 infection. Frontiers in pharmacology, 11, 585408.
الرقم المعياري الدولي للكتاب1663-9812
معرّف المصادر الموحدhttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85094105075&origin=inward
معرّف المصادر الموحدhttp://hdl.handle.net/10576/47151
الملخصThe global pandemic of COVID-19 disease caused by infection with the SARS-CoV-2 coronavirus, has produced an urgent requirement and search for improved treatments while effective vaccines are developed. A strategy for improved drug therapy is to increase levels of endogenous reactive metabolites for selective toxicity to SARS-CoV-2 by preferential damage to the viral proteome. Key reactive metabolites producing major quantitative damage to the proteome in physiological systems are: reactive oxygen species (ROS) and the reactive glycating agent methylglyoxal (MG); cysteine residues and arginine residues are their most susceptible targets, respectively. From sequenced-based prediction of the SARS-CoV-2 proteome, we found 0.8-fold enrichment or depletion of cysteine residues in functional domains of the viral proteome; whereas there was a 4.6-fold enrichment of arginine residues, suggesting SARS-CoV-2 is resistant to oxidative agents and sensitive to MG. For arginine residues of the SARS-CoV-2 coronavirus predicted to be in functional domains, we examined which are activated toward modification by MG – residues with predicted or expected low pKa by neighboring group in interactions. We found 25 such arginine residues, including 2 in the spike protein and 10 in the nucleoprotein. These sites were partially conserved in related coronaviridae: SARS-CoV and MERS. Finally, we identified drugs which increase cellular MG concentration to virucidal levels: antitumor drugs with historical antiviral activity, doxorubicin and paclitaxel. Our findings provide evidence of potential vulnerability of SARS-CoV-2 to inactivation by MG and a scientific rationale for repurposing of doxorubicin and paclitaxel for treatment of COVID-19 disease, providing efficacy and adequate therapeutic index may be established.
راعي المشروع- Qatar Foundation - PhD studentship. - Qatar Foundation - (project code QB-14). - Qatar University - COVID-19 research (project code QU ERG-CMED-2020-1).
اللغةen
الناشرFrontiers Media
الموضوعbioinformatics
coronavirus
COVID-19
doxorubicin
glyoxalase
methylglyoxal
paclitaxel
proteomics
العنوانVulnerabilities of the SARS-CoV-2 Virus to Proteotoxicity—Opportunity for Repurposed Chemotherapy of COVID-19 Infection
النوعArticle
رقم المجلد11
dc.accessType Open Access


الملفات في هذه التسجيلة

Thumbnail

هذه التسجيلة تظهر في المجموعات التالية

عرض بسيط للتسجيلة